3Lotze U,Heinke S,Fritzenwanger M,et al.Carvedilol inhibits platelet- derived growth factor- induced signal transduction in human cardiac fibroblasts[J]. J Cardiovasc Pharmaco12002,39(4):576-589.
4Razeghi P, Sharma S,Ying J,et al.Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation[J].Circulation,2003,108(20): 2536 -2541.
4Rohde J, Heitman J, Cardenas ME. The TOR kinases link nutrient sensing to cell growth[ J] . J Biol Chem, 2001,276(13) : 9583-9586.
5Fingar DC, Blenis J. Target of rapamycin (TOR) : an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression[J]. Oncogene ,2004,23(18) :3151-3171.
6Raught B, Gingras AC, Sonenberg N. The target of rapamycin (TOR) proteins[J]. Proc Natl Acad Sci USA,2001,98(13) :7037-7044.
7Rowinsky EK. Targeting the molecular target of rapamycin ( mTOR )[J] .Curt Opin Oncol,2004,16(6) :564-575.
8Danielpour D. Functions and regulation of transforming growth factorbeta (TGF-β) in the prostate[ J]. Eur J Cancer,2005,41(6) : 846-857.
9Pollheimer J, Knofler M. Signalling pathways regulating the invasive differentiation of human trophoblasts [ J ] . Placenta, 2005,26 [ Suppl A ] :S21-30.
10Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease[J]. Nat Genet ,2005,37(1) : 19-24.
